Sarepta says teen died after its gene therapy treatment
Sarepta Therapeutics said on Tuesday that a 16-year-old boy died from acute liver failure months after receiving the company's U.S-approved gene therapy for a rare muscular dystrophy. The patient ...
CHO Plus Obtains U.S. Patent for Improved Production of Viral Vectors for Gene Therapy
CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announced that U.S. Patent No. 12,252,713 was issued by the United States Patent and Trademark Office. The patent ...
Illuminating brain circuits in the axolotl: Viral vectors enable dynamic brain mapping
The axolotl (Ambystoma mexicanum) has extraordinary regenerative abilities—the salamander can regrow lost limbs and repair ...
PharmiWeb12d
Global Viral Vectors for Non-Human Primates Market to Reach USD 429.9 Mn by 2034, Growing at 10.5% CAGR – TMR Analysis
The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...
NewBiologix Announces White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies
NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining ...
AlphaGalileo12d
Illuminating brain circuits in the axolotl
The axolotl is a powerful model for understanding regeneration, however, studying the axolotl’s nervous system has been ...
Fierce Pharma5h
Sarepta reports 1 death after patient received DMD gene therapy Elevidys
One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech ...
Full Circles Therapeutics Secures U.S. Patent Allowance for Targeted Genome Modification Using Circular Single-Stranded DNA
Full Circles Therapeutics, a leader in next-generation genome engineering, announces that the United States Patent and Trademark Office (USPTO) has allowed its foundational patent titled "TARGETED ...